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BACKGROUND: Pruritus is a common cutaneous manifestation of chronic kidney disease (CKD). It is 
associated with poor sleep quality, anxiety and depression which may contribute to reduction in quality of 
life (QoL). Paying more attention to pruritus in CKD patients may improve their QoL, reduce kidney 
disease burden and mortality. This study determined the prevalence, pattern and association of pruritus 
with QoL in CKD patients. 
MATERIALS AND METHODS: This was a cross-sectional descriptive study carried out in a Kidney 
Care Centre, Ondo City, Southwest  Nigeria. The severity and intensity of pruritus and  health-related 
QoL were assessed using validated instruments. P-value of < 0.05 was taken as significant. 
RESULTS: There were 91 CKD subjects with a male:female ratio of 2.1:1. Sixty-nine (75.8%) of the 
CKD patients were not on dialysis while the remaining twenty-two (24.2%) were on maintenance 
hemodialysis (MHD). Thirty-nine (42.9%) of the CKD subjects had pruritus which was mild in 
25(64.1%), moderate in 8(20.5%) and severe in 6(15.4%). Pruritus was more common in MHD patients 
compared to predialysis CKD patients(50%vs40.6%) p = 0.47. The median pruritus intensity score was 
also higher in MHD patients compared to predialysis CKD patients (40vs30) p = 0.51.  There was no 
significant association between gender, age, aetiology of CKD, stage of CKD and pruritus. There was a 
significant correlation between QoL score  and pruritus intensity. (p = < 0.001, r = 0.56).  
CONCLUSION: Pruritus was  common among our CKD subjects and it was not significantly associated 
with age, gender, stage or etiology of CKD. There was a significant association between impaired QoL 
and pruritus intensity.  
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INTRODUCTION  
 
Pruritus is one of the common cutaneous 
manifestation of chronic kidney disease (CKD) 
that is present in 40-84% of end stage renal 
disease population (1-5).   There is variation in its 
distribution and severity. Uremic pruritus 
frequently affects localized parts of the body such 
as face, chest, back, limbs and may be generalized 
in up to 50% of those affected (6). It may affect 
both predialysis CKD patients and those already 
on renal replacement therapy. There is no 
significant difference between the prevalence of 
pruritus in those on hemodialysis (HD) or 
peritoneal dialysis (PD) (1). 
The exact pathogenesis of pruritus in CKD is 
unknown. However, some pathogenetic 
mechanisms have been suggested. These include 
divalent ion abnormalities such as calcium and 
magnesium, phosphate abnormalities, 
hyperparathyroidism, iron deficiency anaemia, 
xerosis, increased cutaneous mast cells and uremic 
toxins (7-10). 
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Pruritus in CKD patients is associated with poor 
sleep, anxiety and depression which may 
contribute to reduction in overall quality of life 
(QoL) in these patients (1-3,11,12).  Pruritus is 
also associated with increased mortality in CKD 
patients (3,12). There are  therapeutic 
interventions useful in treatment or reduction of 
the severity of uremic pruritus such as 
improvement in adequacy of dialysis, treatment of 
calcium, phosphate abnormalities, correction of 
iron deficiency and  use of ultraviolet B light 
(10,13-15). Therefore, paying more attention to 
pruritus  in these patients may  improve their  
QoL, reduce kidney disease burden and mortality. 
There is still a major gap in the knowledge of 
pruritus and its association with quality of life in 
CKD patients in  Nigeria, hence the need for this 
study which aimed:  
1. To determine the prevalence and pattern 
of pruritus in CKD patients attending 
Kidney Care Centre, Ondo City, 
Southwest Nigeria. 
2. To determine the association between  
pruritus severity and QoL in these CKD 
patients.  
 
MATEIALS AND METHODS  
 
Study design: This was a descriptive cross-
sectional study  carried out in the Kidney Care  
Centre, Ondo City which is a state-government 
owned tertiary hospital located in Southwest 
Nigeria. The study was conducted between 
September 2015 and May 2016.  
Sample size and study population: The 
minimum sample size for this study was 90  after  
including 10% attrition rate using Epi Info sample 
size calculator for a population that is less than 
10,000. The prevalence  of pruritus in CKD 
patients  was  taken as 26.2% from a previous 
study and 95% was used as the confidence interval 
(16). However, a total of 91 CKD subjects were 
recruited for the study. Adult predialysis CKD 
and maintenance HD patients were included 
in the study. Those with with primary skin 
disorder and immunosuppressant therapy were 
excluded. 
The effect of pruritus on QoL of the CKD 
subjects was assessed using ‘Skindex-10’ 
questionnaire which had been previously validated 
for uremic pruritus (5). This questionnaire consists 
of ten questions and each has five options as 
answer (never, rarely, sometimes, often and all the 
time which were scored as 0,1,2,3 and 4 
respectively in this study).  This questionnaire 
assessed sleep, social function and emotion 
domains. The summation of these scores gave the 
QoL score for each patient with pruritus. A “Self-
Assessed Disease Severity” questionnaire which 
allowed patients to categorize themselves into 
mild, moderate and severe, depending on severity 
of concomitant signs and symptoms was used to 
assess pruritus severity. This self-categorization 
instrument had been previously validated and 
found useful to predict intensity and chronicity of 
uremic pruritus (17).  For itching intensity, a 100-
mm visual analog scale (VAS) was used to assess 
pruritus intensity. 
All study subjects were interviewed using an 
interviewer administered questionnaire after 
taking informed consent. This questionnaire had 
sections for demographic data, etiology of CKD, 
pattern of pruritus, severity of pruritus and effect 
of pruritus on QoL of the study subjects. The 
patients were staged according to Kidney Disease 
Improving Global Outcome guidelines (18).   
Data analysis: Data was analyzed using the 
statistical package for social sciences (SPSS) 
version 17.0. Results were presented in tabular 
form. Univariate analysis was used in description 
of the characteristics of the study population. 
Discrete variables were presented as frequency 
and percentages. Continuous variables were 
presented as median, interquartile range while 
Mann Whitney U was used to compare the median 
within sub-groups. Chi-square test was used to 
determine the significance of observed differences 
for categorical variables.  Spearman’s correlation 
was used to determine association between QoL 





The study population consisted of 91 CKD 
subjects with 62 males (68.1%) and 29 females 
(31.9%). The majority of the subjects were less 
than 65 years, accounting for 76(83.6%) of the 
total population. Twenty-two (24.2%) of the CKD 
were on maintenance hemodialysis (MHD), 
53(58.2%) in CKD stage 5, 10(11.0%) in CKD 
stage 4 and 6(6.6%) in CKD stage 3. The common 
etiologies of CKD in the study were chronic 




glomerulonephritis in 33(36.2%), hypertension in 
24(26.4%) and diabetes mellitus in 17(18.7%). 
Thirty-nine (42.9%) of the CKD subjects had 
pruritus. The intensity of pruritus according to self 
categorization was mild in 25(64.1%), moderate in 
8(20.5%) and severe in the remaining 6(15.4%) 
(Table 1).  
 




<45 years 39(42.9) 
45-64 years 37(40.7) 





















CKD (chronic kidney disease) CGN (chronic 
glomerulonephritis), DM (diabetes mellitus),  5† 
(Maintenance HD) 
 
Pruritus was present in 25(40.3%) of the male 
CKD subjects which was lower compared to 
14(48.3%) of the female CKD subjects, although 
this was not significant (p=0.51). Pruritus was 
more common in those with CKD from chronic 
glomerulonephritis and diabetes mellitus 
compared to other etiologies. Pruritus was present 
in 18(45%) of young CKD subjects, 17(44.7%) of 
middle aged CKD subjects and 6(33.3%) of the 
elderly CKD subjects. Although  pruritus was 
more common in young and middle aged CKD 
subjects compared to elderly subjects. This was 
however not significant (p=0.38) (Table 2).  
The proportion of CKD patients on MHD 
with pruritus was higher compared to  predialysis 
CKD patients (50% vs 40.6%), although not 
statistically significant (p=0.47).   There was no 
significant association between gender, age, 
aetiology of CKD, stage of CKD and pruritus 
(Table 2).  
The median VAS of  pruritus intensity of 
predialysis CKD patients was 30(28). This  was 
lower compared to 40(35) in MHD patients. 
However, this was not statistically significant 
(p=0.51). 
Pruritus was generalized in 11(28.2%)  of  the 
CKD subjects. The commonly affected localized 
areas were the limbs in 10(25.7%), trunk in 
9(23.1% ) and a combination of limbs and trunk in 
7(18%) (Fig 1). There was a significant positive 
correlation between QoL score and visual 
analogue score for pruritus intensity (p=<0.001, 
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Figure 1: Frequency of body parts affected by Pruritus 
  
Table 2: Association between Pruritus, age, aetiology and stage of CKD 
 
 Pruritus Present n(%) Pruritus Absent n(%) P-value 
Gender    
Male 25(40.3) 37(59.7) 0.51 
Female 14(48.3) 15(51.7)  
Age    
<45 years 18(45.0) 22(55.0)  
45-64 years 17(44.7) 21(55.3) 0.38 
≥ 65 years 4(30.8) 9(69.2)  
CKD Aetiology    
CGN 15(45.5) 18(54.5%)  
Hypertension 7(29.2) 17(70.8) 0.97 
DM 11(64.7) 6(35.3)  
Others 6(33.3%) 11(66.7%)  
CKD STAGE    
Predialysis 28(40.6) 41(59.4) 0.47 
MHD 11(50.0) 11(50.0)  




Figure 2: Correlation between Pruritus intensity and quality of life score 







This study showed that a significant proportion of 
both MHD and predialysis patients had pruritus 
There was also significant association between  
QoL score  and pruritus intensity among our CKD 
subjects. 
The prevalence of pruritus in this study is 
42.9% which is higher than 18.9% reported by 
Solak et al (19). The higher prevalence in our 
study may be due to the fact that the  study 
subjects consisted of both predialysis CKD and 
MHD  patients unlike those in the study by Solak 
et al who were only  predialysis patients.  Tessari 
et al and Marthur et al however reported a higher 
prevalence of 52.1% and 84 % respectively 
compared to our study. This may be due to the fact 
that all their study subjects were on MHD unlike 
this study (1,5).  
There was no significant difference in th e 
occurrence of pruritus in relation to age, gender, 
CKD stage and aetiology of CKD. This is similar 
to findings reported by Solak et al and Berger et al 
(19,20).  This implies that  pruritus should be 
assessed and managed in all CKD patients 
irrespective of age,  gender, stage or etiology.  
In this study, the prevalence of pruritus was 
higher in MHD patients compared to the 
predialysis patients. The intensity of pruritus was 
also more severe in MHD patients. These may be 
related to higher level of inflammatory markers 
usually observed in HD subjects which have also 
been  implicated in the pathogenesis of uremic 
pruritus (21-23). 
This study also showed that pruritus affected 
the lower limbs and trunk  most commonly  which 
is similar to findings of other previous studies 
(6,24). The pattern of pruritus severity determined 
by self-assessment showed that the majority of the 
CKD subjects in this study had mild to moderate 
pruritus which is different from findings by 
Marthur et al who reported that there were more 
patients with moderate to severe pruritus in their 
study (5).This may also be explained by the fact 
that all patients in the latter study were on HD and 
were more  likely to have severe form of pruritus. 
There was a significant association between 
intensity of pruritus assessed by VAS and quality 
of life scores which is similar to findings in other 
studies (1,3-5, 25). This shows that the quality of 
life of our CKD patients is adversely affected  
with increasing  intensity of pruritus.  Pruritus has 
also been reported to be associated with higher 
mortality risk in CKD patients (3,13). Therefore, 
clinicians should pay more attention to pruritus in 
CKD because of its overall negative impact on 
quality of life and mortality.  VAS is a simple and 
quick method of assessing severity of pruritus 
which may be used to follow up  the effect of 
therapeutic interventions instituted to manage 
pruritus in CKD patients.  
Correction of anemia, calcium-phosphate 
abnormalities and optimizing dialysis may reduce 
severity of pruritus (10,13,15). This may therefore 
improve QoL and reduce mortality of  CKD 
patients. The limitation of this study is that it is a 
single centre study whose findings cannot be 
generalized. Also, calcum-phosphate 
abnormalities which may have association with 
pruritus were not assessed in this study.  
In conclusion, pruritus was  common among 
our CKD subjects, and it was not associated with 
age, gender, stage or aetiology of CKD. There was 
a significant association between QoL score  and 
pruritus intensity.  Therefore, treating pruritus may 
improve QoL of CKD patients.  
Pruritus should be regularly assessed  and 
effectively managed in CKD patients in order to 
reduce associated morbidity, mortality and 




1. Tessari G, DalleVedove C, Loschiavo C, 
Tessitore N, Rugiu C, Lupo A et al.The 
impact of pruritus on the quality of life of 
patients undergoing dialysis: a single centre 
cohort study. J Nephrol. 2009;22(2):241-248. 
2. Zucker I, Yosipovitch G, David M, Gafter U, 
Boner G..Prevalence and characterization of 
uremic pruritus in patients undergoing 
hemodialysis: uremic pruritus is still a major 
problem for patients with end-stage renal 
disease. J Am Acad Dermatol. 2003 
;49(5):842-846. 
3. Pisoni RL, Wikström B, Elder SJ, Akizawa T, 
Asano Y, Keen ML et al Pruritus in 
haemodialysis patients: International results 
from the Dialysis Outcomes and Practice 
Patterns Study (DOPPS). Nephrol. Dial 
Transplant 2006:21(12):3495-3505. 





4. Susel J, Batycka-Baran A, Reich A, 
Szeipetowski JC. Uremic pruritus markedly 
affects quality of life and depressive 
symptoms in hemodialysis patients with end 
stage renal dsease. Acta Derm Venerol 
2014;94(3):276-278. 
5. Mathur VS, Lindberg J, GermainM,Block G, 
Tumlin J, Smith M et al. A longitudinal study 
of uremic pruritus in hemodialysis patients. 
Clin J Am SocNephrol 2010;5(8):1410-1419 
6. Mettang T, Pauli-Magnus C, Alscher DM. 
Uremic pruritus—new perspectivesand 
insights from recent trials. Nephrol Dial 
Transplant 2002;17:1558-1563. 
7. Hiroshige K, Kabashima N, Takasugi M, 
Kuroiwa A. Optimal dialysis improves uremic 
pruritus. Am J Kidney Dis 1995;25:413-419. 
8. Virga G, Visentin I, La Milia V, Bonadonna 
A. Inflammation and pruritus in haemodialysis 
patients. Nephrol Dial Transplant 
2002;17:2164-2169. 
9. Blachley JD, Blankenship M, Menter A, 
Parker T III, Knochel JP. Uremic pruritus: 
skin divalent ion content and response to 
ultraviolet phototherapy. Am J Kidney Dis 
1985;5:237-241. 
10. Hiroshige K, Kabashima N, Takasugi M, 
Kuroiwa A. Optimal dialysis improves uremic 
pruritus. Am J Kidney Dis 1995;25:413-41 
11. Lopes GB, Nogueira FC, de Souza MR, 
Penalva MA, de Amorim JL, Pisoni RL et al. 
Assessment of the psychological burden 
associated with pruritus in hemodialysis 
patients using the kidney disease quality of 
life short form. Qual Life Res 2012;21(4):603-
612.   
12. KimataN, Fuller DS, Saitu A, Akizawa T, 
Fukuhara S, Pisoni RL et al Pruritus in 
hemodialysis patients:Results from Japanese 
Dialysis Outcomes and Practice Patterns 
Study (JDOPPS). Hemodial Int 
2014;18(3):657-667. 
13. Chen ZJ,CaoG,Tang WX, Lv XY, Huang SM, 
Qin W et al. A randomized controlled-trial of 
high permeability haemodialysis against 
conventional haemodialysis in treatment of 
uremic pruritus. Clin Exp Dermatol 
2009;34:679-683.  
14. Ada S, Seçkin D, Budakoğlu I, Ozdemir FN. 
Treatment ofuremic pruritus with narrow band 
ultraviolet B phototherapy: an open pilot 
study. J Am AcadDermatol. 2005;53(1):149-
51. 
15. Noordzij M, BoeschotenEW,Bos WJ, Dekker 
FW, Bossuyt PM, Krediet RT et al.  Disturbed 
mineral metabolism is associated with muscle 
and skin complaints in a prospective cohort of 
dialysis patients. Nephrol Dial Transpl 
2007;22;2944-2949. 
16. Falodun O, Ogunbyi A, Salako B, George AK. 
Skin changes in patientswth chronic renal 
failure. Saudi J Kidney Dis Transpl 
2011;22:268-272. 
17. Bhaduri S, Mathur V, Fellmann J, Rosen D. 
Uremic puritus patients: A national survey of 
sleep and mood disruption. Am J Kid Dis 
2007; 49:31. 
18. National Kidney Foundation. KDIGO 2012 
Clinical Practice Guideline for the Evaluation 
and Management of Chronic Kidney Disease. 
Kidney Int Suppl 2013;3:19-62. 
19. Solak B, Acikgoz SB, Sipahi S, Erdem T. 
Epidemiology and determinants of pruritus in 
pre-dialysis chronic kidney disease patients. 
Int Urol Nephrol. 2016;48(4):585-91. 
20. Berger TG, Steinhoff M. Pruritus and renal 
failure. Semin Cut Med Surg 2011;30(2):99-
100. 
21. Chen HY, Chiu YL, Hsu SP,Pai MF, Lai CF, 
Yang JY. Elevated C-reactive protein level in 
hemodialysis patients with moderate/severe 
uremic pruritus: a potential mediator of high 
overall mortality. QJM 2010;103:837–846. 
22. Fallahzadeh MK, Roozbeh J, Geramizadeh B, 
Namazi MR.  Interleukin-2 serum levels are 
elevated in patients with uremic pruritus: a 
novel finding with practical implications. 
Nephrol Dial Transplant 2011;26:3338–334. 
23. Takahashi T, Kubota M, Nakamura T, Ebihara 
I, Koide H. Interleukin-6 gene expression in 
peripheral blood mononuclear cells from 
patients undergoing hemodialysis or 
continuous ambulatory peritoneal dialysis. 
Ren Fail 2000;22:345–354. 
24. Subach RA, Marx MA.Evaluation of uremic 
pruritus at an outpatient hemodialysis unit. 
Ren Fail. 2002;24(5):609-14. 
25. Szepietowski JC, Balaskas E, Taube 
KM,Taberly A, Dupuy P. Quality of life in 
patients with uremic xerosis and pruritus. Acta 
Derm Venerology 2011;91(3):313-317. 
